[1] Baxi AC, Jiang Q, Hao J,et al. The effect of solid pancreatic mass lesions on pancreatic duct diameter at endoscopic ultrasound[J].Endosc Ultrasound,2017, 6(2):103-108. [2] Hoshimoto S, Aiura K, Tanaka M, et al. Mass-forming type 1 autoimmune pancreatitis mimicking pancreatic cancer[J].J Dig Dis,2016, 17(3):202-209. [3] Zhiping W, Quwen L, Hai Z, et al. Application of molecular imaging combined with genetic screening in diagnosing MELAS, diabetes and recurrent pancreatitis[J].Folia Neuropathol,2016,54(1):66-71. [4] Zhang D, Xu A. Application of dual-source CT perfusion imaging and MRI for the diagnosis of primary liver cancer[J].Oncol Lett,2017,14(5):5753-5758. [5] 中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南[J]. 中国实用外科杂志, 2014, 34(11):1011-1017. [6] Yadav AK, Sharma R, Kandasamy D, et al. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum[J]?Pancreatology,2016,16(6):979-987. [7] Saraswat M, Joenv r S, Seppnen H, et al. Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis[J].Cancer Med,2017, 6(7): 1738-1751. [8] Poddar N, Ramlal R, Ravulapati S, et al. Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence[J].Curr Oncol,2017, 24(4): e333-e336. [9] Lee DH, Kim SH, Im SA, et al. Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: A preliminary study[J].Eur Radiol,2016, 26(8):2771-2778. [10] Hashemieh M, Radfar M, Azarkeivan A, et al. T2 magnetic resonance imaging study of pancreatic iron overload and its relation with the diabetic state in thalassemic patients[J].J Pediatr Hematol Oncol,2017, 39(5): 337-340. [11] Ko SE, Choi IY, Cha SH, et al. Clinical and radiologic characteristics of pancreatic head carcinoma without main pancreatic duct dilatation: using dual-phase contrast-enhanced CT scan[J].Clin Imaging,2016, 40(3):548-552.
2019, Vol. 36 
